BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 36307554)

  • 21. Impact of feature selection methods and subgroup factors on prognostic analysis with CT-based radiomics in non-small cell lung cancer patients.
    Sugai Y; Kadoya N; Tanaka S; Tanabe S; Umeda M; Yamamoto T; Takeda K; Dobashi S; Ohashi H; Takeda K; Jingu K
    Radiat Oncol; 2021 Apr; 16(1):80. PubMed ID: 33931085
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A prognostic analysis method for non-small cell lung cancer based on the computed tomography radiomics.
    Wang X; Duan H; Li X; Ye X; Huang G; Nie S
    Phys Med Biol; 2020 Feb; 65(4):045006. PubMed ID: 31962301
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CT-based radiomics signatures can predict the tumor response of non-small cell lung cancer patients treated with first-line chemotherapy and targeted therapy.
    Yang F; Zhang J; Zhou L; Xia W; Zhang R; Wei H; Feng J; Zhao X; Jian J; Gao X; Yuan S
    Eur Radiol; 2022 Mar; 32(3):1538-1547. PubMed ID: 34564744
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Towards a survival risk prediction model for metastatic NSCLC patients on durvalumab using whole-lung CT radiomics.
    Patwardhan KA; RaviPrakash H; Nikolaou N; Gonzalez-García I; Salazar JD; Metcalfe P; Reischl J
    Front Immunol; 2024; 15():1383644. PubMed ID: 38915397
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A short-term follow-up CT based radiomics approach to predict response to immunotherapy in advanced non-small-cell lung cancer.
    Gong J; Bao X; Wang T; Liu J; Peng W; Shi J; Wu F; Gu Y
    Oncoimmunology; 2022; 11(1):2028962. PubMed ID: 35096486
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Identifying sarcopenia in advanced non-small cell lung cancer patients using skeletal muscle CT radiomics and machine learning.
    Dong X; Dan X; Yawen A; Haibo X; Huan L; Mengqi T; Linglong C; Zhao R
    Thorac Cancer; 2020 Sep; 11(9):2650-2659. PubMed ID: 32767522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Radiomics Signature in Preoperative Predicting Degree of Tumor Differentiation in Patients with Non-small Cell Lung Cancer.
    Chen X; Fang M; Dong D; Wei X; Liu L; Xu X; Jiang X; Tian J; Liu Z
    Acad Radiol; 2018 Dec; 25(12):1548-1555. PubMed ID: 29572049
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Prognostic analysis and risk stratification of lung adenocarcinoma undergoing EGFR-TKI therapy with time-serial CT-based radiomics signature.
    Zhang X; Lu B; Yang X; Lan D; Lin S; Zhou Z; Li K; Deng D; Peng P; Zeng Z; Long L
    Eur Radiol; 2023 Feb; 33(2):825-835. PubMed ID: 36166088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Development of a radiomics nomogram based on the 2D and 3D CT features to predict the survival of non-small cell lung cancer patients.
    Yang L; Yang J; Zhou X; Huang L; Zhao W; Wang T; Zhuang J; Tian J
    Eur Radiol; 2019 May; 29(5):2196-2206. PubMed ID: 30523451
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intratumoral and peritumoral radiomics nomograms for the preoperative prediction of lymphovascular invasion and overall survival in non-small cell lung cancer.
    Chen Q; Shao J; Xue T; Peng H; Li M; Duan S; Feng F
    Eur Radiol; 2023 Feb; 33(2):947-958. PubMed ID: 36064979
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Radiomics study for predicting the expression of PD-L1 in non-small cell lung cancer based on CT images and clinicopathologic features.
    Sun Z; Hu S; Ge Y; Wang J; Duan S; Song J; Hu C; Li Y
    J Xray Sci Technol; 2020; 28(3):449-459. PubMed ID: 32176676
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Performance of radiomics models for survival prediction in non-small-cell lung cancer: influence of CT slice thickness.
    Park S; Lee SM; Kim S; Choi S; Kim W; Do KH; Seo JB
    Eur Radiol; 2021 May; 31(5):2856-2865. PubMed ID: 33128185
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and Validation of a CT-Based Signature for the Prediction of Distant Metastasis Before Treatment of Non-Small Cell Lung Cancer.
    Tao J; Lv R; Liang C; Fang J; Liu D; Lan X; Huang H; Zhang J
    Acad Radiol; 2022 Feb; 29 Suppl 2():S62-S72. PubMed ID: 33402298
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sublobar Resection in Stage IA Non-Small Cell Lung Cancer: Role of Preoperative CT Features in Predicting Pathologic Lymphovascular Invasion and Postoperative Recurrence.
    Choe J; Kim MY; Yun JK; Lee GD; Kim YH; Choi S; Kim DK
    AJR Am J Roentgenol; 2021 Oct; 217(4):871-881. PubMed ID: 33978462
    [No Abstract]   [Full Text] [Related]  

  • 35. Radiomics for Survival Risk Stratification of Clinical and Pathologic Stage IA Pure-Solid Non-Small Cell Lung Cancer.
    Wang T; She Y; Yang Y; Liu X; Chen S; Zhong Y; Deng J; Zhao M; Sun X; Xie D; Chen C
    Radiology; 2022 Feb; 302(2):425-434. PubMed ID: 34726531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Correlation between CT based radiomics features and gene expression data in non-small cell lung cancer.
    Wang T; Gong J; Duan HH; Wang LJ; Ye XD; Nie SD
    J Xray Sci Technol; 2019; 27(5):773-803. PubMed ID: 31450540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The use of texture-based radiomics CT analysis to predict outcomes in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy.
    Starkov P; Aguilera TA; Golden DI; Shultz DB; Trakul N; Maxim PG; Le QT; Loo BW; Diehn M; Depeursinge A; Rubin DL
    Br J Radiol; 2019 Feb; 92(1094):20180228. PubMed ID: 30457885
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Development and evaluation of a venous computed tomography radiomics model to predict lymph node metastasis from non-small cell lung cancer.
    Cong M; Yao H; Liu H; Huang L; Shi G
    Medicine (Baltimore); 2020 May; 99(18):e20074. PubMed ID: 32358390
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Peritumoral radiomics features on preoperative thin-slice CT images can predict the spread through air spaces of lung adenocarcinoma.
    Takehana K; Sakamoto R; Fujimoto K; Matsuo Y; Nakajima N; Yoshizawa A; Menju T; Nakamura M; Yamada R; Mizowaki T; Nakamoto Y
    Sci Rep; 2022 Jun; 12(1):10323. PubMed ID: 35725754
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Development of a radiomics signature to predict Ki-67 expression level in non-small cell lung cancer].
    Gu Q; Feng Z; Liang Q; Li M; Wang W; Rong P
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2018 Nov; 43(11):1216-1222. PubMed ID: 30643066
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.